The Latest Breaking News from Starboard

BILL Holdings, Inc. (NYSE:BILL) is trading higher after reaching a cooperation agreement with Starboard Value, which adds new directors and sharpens the company’s focus on profitability, efficiency, and long-term growth for its finance platform serving small and mid-sized businesses.

Less than a week after Starboard Value reported a stake in Bill Holdings Inc (NYSE:BILL), a new report links activist hedge fund Elliott Management to taking a stake in the payments company.

Pfizer is getting back on track—but an even more potent prescription for success could be in the cards for the pharmaceutical giant under.

Starboard Value is reportedly eyeing changes at KVUE as the stock underperforms the broader market.

This dividend stock is now on the radar of activist investors, with Starboard eyeing a possible management shakeup.

'Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff Sonnenfeld and Steven Tian.

Despite its dividend yield of nearly 6%, Pfizer stock has failed to win over investors and is in the red YTD. Can the stock finally stage a turnaround, as activist investor Starboard Value has reportedly taken a stake in the company?

The drugmaker has shed nearly $180 billion in market cap after struggling to chart a new course as the COVID-19 pandemic waned.

Starboard has reached out to former Pfizer CEO Ian Read and ex-finance chief Frank D'Amelio, and both have expressed interest in supporting the activist investor's turnaround efforts, reports said.